Загрузка...
“Don’t Phos Over Tau”: recent developments in clinical biomarkers and therapies targeting tau phosphorylation in Alzheimer’s disease and other tauopathies
Phosphorylation is one of the most prevalent post-translational modifications found in aggregated tau isolated from Alzheimer’s disease (AD) patient brains. In tauopathies like AD, increased phosphorylation or hyperphosphorylation can contribute to microtubule dysfunction and is associated with tau...
Сохранить в:
| Опубликовано в: : | Mol Neurodegener |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8180161/ https://ncbi.nlm.nih.gov/pubmed/34090488 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13024-021-00460-5 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|